Masatoshi Kudo

Statistics

Publications

Citations

H-Index

Active since

2025

Affiliations

National Cancer Center Hospital East(Current)

Kanagawa Cancer Center

Musashino Red Cross Hospital

Aichi Cancer Center

Kanazawa University Hospital

Masatoshi Kudo is an author at National Cancer Center Hospital East specializing in metastatic cancer management, chemotherapy, and combination chemotherapy.

Publications per year

2025–2025

Publications

Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin or S-1, Irinotecan, and Oxaliplatin Versus Nab-Paclitaxel + Gemcitabine in Metastatic or Recurrent Pancreatic Cancer (GENERATE, JCOG1611): A Randomized, Open-Label, Phase II/III Trial

Akihiro Ohba, Masato Ozaka, Junki Mizusawa et al. · Journal of Clinical Oncology · 2025 · 18 citations · Full text

Medicine, Oncology, Pharmacology +15

Depth and Duration of Response Are Associated with Survival in Patients with Unresectable Hepatocellular Carcinoma: Exploratory Analyses of IMbrave150

Masatoshi Kudo, Tatsuya Yamashita, Richard S. Finn et al. · Liver Cancer · 2025 · 11 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma

Yoshihisa Kodama, Kazuomi Ueshima, Michihisa Moriguchi et al. · BMC Cancer · 2025 · 10 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

1–3 of 3